The IPO Buzz: Biotechs BlossomHill & Latigo Upsize IPOs & Raise $495.6 Million Total
Upsized is the biotech word of the week. BlossomHill Therapeutics (BLSM) and Latigo Biotherapeutics (LTGO) increased the size of their IPOs at pricing and raised a total of $495.6 million on Thursday night (Aug. 6, 2026). The upsized trend held for all four biotech IPOs priced this week, including Attovia Therapeutics (ATTO) and Braveheart Bio (BRVE). Altogether, these four biotech..
Read more August 7, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| BlossomHill Therapeutics | BLSM | 9.4 | $ 150.0 mil | 8/7/2026 Priced | S/O | S/O |
| Latigo Biotherapeutics | LTGO | 19.2 | $ 345.6 mil | 8/7/2026 Priced | S/O | S/O |
| OceanLight Acquisition | OCLT | 10.0 | $ 100.0 mil | 8/7/2026 Priced | S/O | S/O |
Last 100 IPOs - August 7, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 59 |
| Number Down: | 37 |
| Number Unchanged: | 4 |
| Percentage Change From Issue Price: | 8.28% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - August 7, 2026
| Number of IPOs priced (Excluding 138 units) : | 110 |
| Number Up: | 62 |
| Number Down: | 44 |
| Number Unchanged: | 4 |
| Total Return From Issue Price: | 6.85% |
| The Nasdaq Composite Index YTD % Change | 35.22% |